StockWatch
·

Orchid Pharma Ltd Q1 FY26 Results

ORCHPHARMAQ1 FY26 Results
Filing
MetricValue ( Cr)vs Q4 FY25
Revenue172.9327.2%
Total Income184.3823.6%
Expenditure170.6723.2%
PBT13.7128.2%
Net Profit14.9133.1%
OPM8.20%3.58pp
NPM8.09%1.15pp
EPS2.9433.2%
View full financials

Informational and educational content only. Not investment advice.